Transaction in Own Shares
Summary by AI BETAClose X
Informa PLC Press Release
10 September 2025
Informa Share Buyback Programme
Update on shareholder returns
Informa PLC ('the Company') (LSE: INF.L), the international B2B Events, B2B Digital Services and Academic Markets Group today provided an update on its share buyback programme
Share Buyback Programme
As part of Informa's Capital Allocation programme, the Company has a commitment to delivering consistent shareholder returns, including through share buybacks. In 2025, the Company has committed a minimum of £350m to its share buyback programme.
On 8 September 2025, the Company purchased 171,500 ordinary shares for cancellation through Numis Securities Limited ("Deutsche Numis") at an average price of 899.36 pence per share. The highest and lowest purchase price paid per share were 905.80 and 892.20 respectively, with the aggregate details of shares purchased by trading venue as outlined in the table below:
|
Venue |
Weighted average price paid per share (GBp) |
Aggregate number of shares purchased |
Lowest price paid per share (GBp) |
Highest price paid per share (GBp) |
|
London Stock Exchange |
899.4739 |
101,500 |
892.20 |
905.80 |
|
Chi-X (CXE) |
899.1614 |
20,000 |
892.60 |
905.20 |
|
BATS (BXE) |
899.2131 |
50,000 |
892.40 |
905.00 |
Following settlement of the above purchases and cancellation of the purchased ordinary shares, the Company's total number of ordinary shares in issue, and its total voting rights, will be 1,298,186,147 ordinary shares. The Company does not hold any shares in Treasury.
In accordance with Article 5(1)(b) of the Market Abuse Regulation, a full breakdown of the individual trades made as part of the buyback programme is detailed in the attachment.
http://www.rns-pdf.londonstockexchange.com/rns/6587Y_1-2025-9-9.pdf
|
Enquiries |
|
|
Richard Menzies-Gow, Director of IR & Communications |
+44 (0) 20 8052 2787 |
|
Heledd Hanscomb, Deputy Company Secretary |
+44 (0) 20 8052 0661 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 9 hours ago Luceco
- 9 hours ago Helios Towers
- 10 hours ago Wise Class A
- 10 hours ago EDX Medical Group Plc
- 10 hours ago Naked Wines